Cited by 160Tuberculosis Research and EpidemiologyGut microbiota and healthInfectious Diseases and Tuberculosis

The DOI matches its Crossref record; 50 of the 50 references it cites were found in a registry or an index.

Anaerobic bacterial fermentation products increase tuberculosis risk in antiretroviral-drug-treated HIV patients.

Open access
Segal, Leopoldo N., Clemente, Jose C., Li, Yonghua, Ruan, Chunhai, Cao, Jane, Danckers, Mauricio, Morris, Alison, Tapyrik, Sarah, Wu, Benjamin G., Diaz, Philip, Calligaro, Gregory, Dawson, Rodney, van Zyl-Smit, Richard N., Dheda, Keertan, Rom, William N., Weiden, Michael D.·2017·Cell Host & Microbe

Abstract

Despite the immune-reconstitution with antiretroviral therapy (ART), HIV-infected individuals remain highly susceptible to tuberculosis (TB) and have an enrichment of oral anaerobes in the lung. Products of bacterial anaerobic metabolism, like butyrate and other short-chain fatty acids (SCFAs), induce regulatory T cells (Tregs). We tested whether SCFAs contribute to poor TB control in a longitudinal cohort of ART-treated HIV-infected South Africans. Increase in serum SCFAs was associated with increased TB susceptibility. SCFAs inhibited IFN-γ and IL-17A production in peripheral blood mononuclear cells from HIV-infected ART-treated individuals in response to M. tuberculosis antigen stimulation. Pulmonary SCFAs correlated with increased oral anaerobes, such as Prevotella in the lung, and with M. tuberculosis antigen-induced Tregs. Metabolites from anaerobic bacterial fermentation may, therefore, increase TB susceptibility by suppressing IFN-γ and IL-17A production during the cellular immune response to M. tuberculosis.

Overview

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1016/j.chom.2017.03.003

Cites

50 of 50 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Flagged first, then by citations

Show all 50 references

Cited by

Sorted by citations

Items 101–160 of 160

Metadata

Authors
Segal, L. N., Clemente, J. C., Li, Y., Ruan, C., Cao, J., Danckers, M., Morris, A., Tapyrik, S., Wu, B. G., Diaz, P., Calligaro, G., Dawson, R., van Zyl-Smit, R. N., Dheda, K., Rom, W. N., & Weiden, M. D.
Affiliations
  • New York University (US)
  • University of Michigan (US)
  • University of Pittsburgh (US)
  • The Ohio State University (US)
  • University of Cape Town (ZA)
Corresponding author
Weiden, Michael D.
Venue
Cell Host & Microbe
Publisher
Elsevier BV
Published
2017-04
Volume
21
Issue
4
Pages
530-537.e4
ISSN
1931-3128 (ISSN-L)
OpenAlex
W2602210733
Cited by
160
References
50
Citations by year
2026: 17 · 2025: 20 · 2024: 32 · 2023: 16 · 2022: 17 · 2021: 20 · 2020: 9 · 2019: 11 · 2018: 12 · 2017: 5
FWCI
7.79
Type
journal article
Language
en
Open access
Locations
  • Cell Host & Microbe (publishedVersion)
  • PubMed (publishedVersion)
  • PubMed Central (acceptedVersion)
Funders
  • NIAID (P30CA016087, K23 AI102970, K24 AI080298A)
  • NIH (RO1HL090316, U24 DK097153)
  • Early Detection Research Network (5U01CA086137-13)
  • Clinical and Translational Science Institute (UL1 TR000038)
Topics
  • Health Sciences › Medicine › Infectious Diseases › Tuberculosis Research and Epidemiology
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Gut microbiota and health
  • Health Sciences › Medicine › Infectious Diseases › Infectious Diseases and Tuberculosis
Keywords
tuberculosis, HIV, antiretroviral therapy, short-chain fatty acids, butyrate, regulatory T cells, oral anaerobes, Prevotella, Mycobacterium tuberculosis, interferon-gamma, IL-17A, cell-mediated immunity, lung microbiome, tuberculosis susceptibility
MeSH terms
Bacteria, Anaerobic, Disease Susceptibility, Fatty Acids, Volatile, Humans, Immunologic Factors, Interferon-gamma, Leukocytes, Mononuclear, Longitudinal Studies, Lung, Mycobacterium tuberculosis, South Africa, Tuberculosis, Pulmonary, HIV Infections, Interleukin-17, Anti-Retroviral Agents, T-Lymphocytes, Regulatory

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review